{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:09:57Z","timestamp":1792454997117,"version":"4.5.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.vaccine.2016.02.030","type":"journal-article","created":{"date-parts":[[2016,2,20]],"date-time":"2016-02-20T18:41:02Z","timestamp":1455993662000},"page":"1810-1815","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Venom conjugated polylactide applied as biocompatible material for passive and active immunotherapy against scorpion envenomation"],"prefix":"10.1016","volume":"34","author":[{"given":"Sana","family":"Ayari-Riabi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Trimaille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamel","family":"Mabrouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Bertin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Gigmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zakaria","family":"Benlasfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahlem","family":"Zaghmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balkiss","family":"Bouhaouala-Zahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Elayeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.02.030_bib0120","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.actatropica.2008.05.021","article-title":"Epidemiology of scorpionism: a global appraisal","volume":"107","author":"Chippaux","year":"2008","journal-title":"Acta Trop"},{"key":"10.1016\/j.vaccine.2016.02.030_bib0125","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1378\/chest.97.1.118","article-title":"Vasodilators and hypertensive encephalopathy following scorpion envenomation in children","volume":"97","author":"Sofer","year":"1990","journal-title":"Chest"},{"key":"10.1016\/j.vaccine.2016.02.030_bib0130","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1432-1033.1970.tb01111.x","article-title":"Purification of animal neurotoxins. Isolation and characterization of eleven neurotoxins from the venoms of the scorpions Androctonus australis hector, Buthus occitanus tunetanus and Leiurus quinquestriatus quinquestriatus","volume":"16","author":"Miranda","year":"1970","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.vaccine.2016.02.030_bib0135","first-page":"325","article-title":"Scorpion toxins: chemistry and mode of action","volume":"3","author":"Rochat","year":"1979","journal-title":"Adv Cytopharmacol"},{"key":"10.1016\/j.vaccine.2016.02.030_bib0140","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.toxicon.2004.10.007","article-title":"Pharmacokinetic studies of scorpion venom before and after antivenom immunotherapy","volume":"45","author":"Krifi","year":"2005","journal-title":"Toxicon"},{"key":"10.1016\/j.vaccine.2016.02.030_bib0145","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1016\/j.vaccine.2004.12.027","article-title":"Immunology of scorpion toxins and perspectives for generation of anti venom vaccines","volume":"23","author":"Gazarian","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.02.030_bib0150","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0169-409X(97)00048-3","article-title":"Biodegradation and biocompatibility of PLA and PLGA microspheres","volume":"28","author":"Shive","year":"1997","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2016.02.030_bib0155","first-page":"1059","article-title":"Effect of alum on in vitro release profile and immunogenicity of microencapsulated tetanus toxoid","volume":"28","author":"Katare","year":"2001","journal-title":"Proc Int Symp Control Release Bioact Mater"},{"key":"10.1016\/j.vaccine.2016.02.030_bib0160","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1023\/A:1015832302605","article-title":"Controlled delivery of diphtheria toxoid using biodegradable poly (d,l-lactide) microcapsules","volume":"8","author":"Singh","year":"1991","journal-title":"Pharm Res"},{"key":"10.1016\/j.vaccine.2016.02.030_bib0165","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jconrel.2006.07.006","article-title":"Coadsorption of HIV-1 p24 and gp120 proteins to surfactant-free anionic PLA nanoparticles preserves antigenicity and immunogenicity","volume":"115","author":"Lamalle-Bernard","year":"2006","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2016.02.030_bib0170","unstructured":"Fessi H, Devissaguet JP, Francis Puisieux F, Thies C. Process for the preparation of dispersible colloidal systems of a substance in the form of nanoparticles. US Patent No. 005118528A; 1991."},{"key":"10.1016\/j.vaccine.2016.02.030_bib0175","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/0264-410X(91)90012-U","article-title":"In vivo protection against scorpion toxins by liposomal immunization","volume":"9","author":"Chavez-Olortegui","year":"1991","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.02.030_bib0180","series-title":"Progress in the characterization of venoms and standardization of antivenoms. Offset publication no. 58","author":"World Health Organization","year":"1981"},{"key":"10.1016\/j.vaccine.2016.02.030_bib0200","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0041-0101(96)00187-0","article-title":"Molecular characterization, antigenicity and immunogenicity of anatoxic polymeric forms conferring protection against scorpion venoms","volume":"35","author":"Kharrat","year":"1997","journal-title":"Toxicon"},{"key":"10.1016\/j.vaccine.2016.02.030_bib0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2015.09.045","article-title":"Enhancement of long-lasting immunoprotective effect against Androctonus australis hector envenomation using safe antigens: comparative role of MF59 and alum adjuvants","author":"Nouri","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.02.030_bib0210","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/nnano.2013.254","article-title":"Nanoparticle detained toxins for safe and effective vaccination","volume":"8","author":"Hu","year":"2013","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.vaccine.2016.02.030_bib0215","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.toxicon.2012.09.010","article-title":"Serum production against Tityus serrulatus scorpion venom using cross-linked chitosan nanoparticles as immunoadjuvant","volume":"60","author":"Rocha Soares","year":"2012","journal-title":"Toxicon"},{"key":"10.1016\/j.vaccine.2016.02.030_bib0190","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0378-5173(02)00079-0","article-title":"Coating of cationized protein on engineered nanoparticles results in enhanced immune responses","volume":"238","author":"Mumper","year":"2002","journal-title":"Int J Pharm"},{"key":"10.1016\/j.vaccine.2016.02.030_bib0220","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0169-409X(98)00008-8","article-title":"Aluminum compounds as vaccine adjuvants","volume":"32","author":"Gupta","year":"1998","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2016.02.030_bib0225","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/0041-0101(83)90276-3","article-title":"Immunochemistry of scorpion alpha-toxins: antigenic homologies checked with radioimmunoassays (RIA)","volume":"21","author":"El Ayeb","year":"1983","journal-title":"Toxicon"},{"key":"10.1016\/j.vaccine.2016.02.030_bib0230","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1432-1033.1989.tb14735.x","article-title":"Structure\/activity relationships of scorpion alpha-toxins: multiple residues contribute to the interaction with receptors","volume":"181","author":"Kharrat","year":"1989","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.vaccine.2016.02.030_bib0185","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/ilar.46.3.280","article-title":"Adjuvants and antibody production: dispelling the myths associated with Freund's complete and other adjuvants","volume":"46","author":"Stills","year":"2005","journal-title":"ILAR J"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16001729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16001729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T20:57:23Z","timestamp":1536958643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16001729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":22,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0264410X16001729"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.02.030","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Venom conjugated polylactide applied as biocompatible material for passive and active immunotherapy against scorpion envenomation","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.02.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}